Bayer boosted by strong earnings in pharmaceutical unit – Financial Times


Financial Times
Bayer boosted by strong earnings in pharmaceutical unit
Financial Times
Bayer, the German aspirin-to-chemicals conglomerate which is in the process of buying US seed giant Monsanto, reported record operating results for 2016 on the back of a strong performance by its pharmaceutical division. Sample the FT’s top stories for
We price drugs in line with innovation potential, says Bayer CEOCNBC

all 32 news articles >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd